Coston McIsaac & Partners’s Colgate-Palmolive CL Stock Holding History

Coston McIsaac & Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$424K	Buy	4,639 +67	+1%	+$5.86K	0.09%	98
2026 Q1	$389K	Sell	4,572 -100	-2%	-$8.91K	0.09%	96
2025 Q4	$369K	Sell	4,672 -108	-2%	-$8.47K	0.09%	100
2025 Q3	$381K	Sell	4,780 -201	-4%	-$17.1K	0.09%	96
2025 Q2	$452K	Buy	4,981 +19	+0.4%	+$1.74K	0.12%	87
2025 Q1	$464K	Sell	4,962 -1,004	-17%	-$89.9K	0.14%	80
2024 Q4	$541K	Sell	5,966 -924	-13%	-$88.2K	0.16%	78
2024 Q3	$714K	Sell	6,890 -318	-4%	-$32.4K	0.2%	65
2024 Q2	$698K	Sell	7,208 -231	-3%	-$21.3K	0.22%	63
2024 Q1	$669K	Buy	7,439 +18	+0.2%	+$1.52K	0.21%	64
2023 Q4	$591K	Sell	7,421 -3	-0%	-$226	0.21%	67
2023 Q3	$527K	Sell	7,424 -108	-1%	-$8.07K	0.2%	66
2023 Q2	$580K	Sell	7,532 -181	-2%	-$14K	0.2%	72
2023 Q1	$579K	Sell	7,713 -214	-3%	-$15.9K	0.22%	72
2022 Q4	$624K	Buy	7,927 +43	+0.5%	+$3.22K	0.24%	67
2022 Q3	$553K	Buy	7,884 +17	+0.2%	+$1.33K	0.25%	64
2022 Q2	$630K	Buy	+7,867	New	+$615K	0.38%	50

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Coston McIsaac & Partners's CL Position: Q2 2026 in Review

Coston McIsaac & Partners increased its Colgate-Palmolive (CL) stake by 1.5% in Q2 2026, buying an estimated $5.86K and bringing the position to 4,639 shares worth $424K. The position accounts for 0.09% of the portfolio, ranked #98.

Coston McIsaac & Partners first reported a position in CL in Q2 2022 and has held it in 17 quarters since. The position peaked at $714K in Q3 2024. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Coston McIsaac & Partners held 4,639 shares of Colgate-Palmolive worth $424K as of Q2 2026.
Coston McIsaac & Partners bought 67 Colgate-Palmolive shares in Q2 2026, an estimated $5.86K.
Colgate-Palmolive made up 0.09% of Coston McIsaac & Partners's portfolio in Q2 2026, its #98 holding.
Coston McIsaac & Partners first reported a position in Colgate-Palmolive in Q2 2022 and has held it in 17 quarters since.
Coston McIsaac & Partners's Colgate-Palmolive position peaked at $714K in Q3 2024.
2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.